Validation of the Performance of the French Version of the Cerebellar Cognitive-Affective Syndrome Scale (CCASS) as a Screening Test for Cerebellar Cognitive-affective Syndrome: a National Multicenter Study

NARecruitingINTERVENTIONAL
Enrollment

217

Participants

Timeline

Start Date

November 9, 2023

Primary Completion Date

October 31, 2026

Study Completion Date

March 31, 2027

Conditions
Cerebellar Cognitive-affective Syndrome
Interventions
DIAGNOSTIC_TEST

Cerebellar Cognitive-Affective Syndrome Scale

The CCASS will be administered by a neuropsychologist starting with version 1A. An alternative version (1B, 1C or 1D) will also be administered. An interval of approximately 30 minutes should be observed between the two administrations. In order to assess the inter-rater reliability of the scale, a second neuropsychologist will be present in the room and will independently evaluate (i.e., blind to his/her colleague's rating) patient's responses. The choice of alternative version (i.e., 1B, 1C, or 1D) will be randomized.

Trial Locations (1)

68100

RECRUITING

GHRMSA, Mulhouse

All Listed Sponsors
lead

Groupe Hospitalier de la Region de Mulhouse et Sud Alsace

OTHER